Leymus Genomics ApS: Financial statements 2018
CVR: 38106872
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Leymus Genomics ApS (CVR 38106872) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -185,782 and a net result of DKK -228,302. Equity in the 2018 report amounted to DKK 160,859. The solvency ratio was 73.1%.
- Gross Profit
- DKK -185,782
- Profit/Loss
- DKK -228,302
- Equity
- DKK 160,859
- Total Assets
- DKK 219,929
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Leymus Genomics ApS has published its interim report for the period October 1, 2016 to December 31, 2017.
About Leymus Genomics ApS
Leymus Genomics ApS was a Danish company of the type Anpartsselskab based in Herlev, founded in 2016. The company has been dissolved on 28 November 2024. The company was registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named Leymus Scientific Capital ApS. The company has 3 employees (2023). In 2023, the company reported a gross profit of DKK -1,341,461 and a net result of DKK -1,269,016 compared with DKK -1,655,772 the year before. Equity in the 2023 report amounted to DKK -124,553.